We have also seen that inhibition of FADS1 antagonizes AML cell growth and survival in experimental models of MLL-rearranged– or FLT3ITD-AML indicating that FADS1 plays an important functional role in the pathogenesis of these AML subtypes. The gene discussed is KMT2A; the disease is acute myeloid leukemia.